These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 363332)

  • 21. Treatment of type II and type IV Fredrickson's hyperlipoproteinemia.
    Crepaldi G; Fellin R; Briani G
    Adv Exp Med Biol; 1973; 38():199-217. PubMed ID: 4766527
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of cholestyramine on the absorption of various drugs in man].
    Hahn KJ; Weber E
    Verh Dtsch Ges Inn Med; 1972; 78():1567-70. PubMed ID: 4665610
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present status of antilipemic agents].
    Takekoshi N; Murakami E
    Nihon Rinsho; 1980 Sep; 38(9):3138-48. PubMed ID: 7019504
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view].
    Mertz DP
    Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipid lowering agents.
    Br Med J; 1972 Jun; 2(5814):642-3. PubMed ID: 5031693
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diet and drug therapy of hyperlipoproteinemia].
    Sirtori C
    Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507
    [No Abstract]   [Full Text] [Related]  

  • 28. The mechanism of action of lipid-lowering drugs.
    LaRosa JC
    Angiology; 1982 Sep; 33(9):562-76. PubMed ID: 7125296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic orientation in the hyperlipidemias].
    Forti N; Diament J; Giannini SD
    Arq Bras Cardiol; 1979 Sep; 33(3):207-15. PubMed ID: 396911
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy of the hyperlipoproteinemias.
    Bagdade JD
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():98-110. PubMed ID: 4605376
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
    Albertini F
    Sem Hop Ther; 1977 Apr; 53(4):261-3. PubMed ID: 882873
    [No Abstract]   [Full Text] [Related]  

  • 32. [Undesirable effects of hypolipemic drugs].
    Schettler G
    Clin Ter; 1980 Mar; 92(5):457-67. PubMed ID: 7449323
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of coronary heart disease with diet and lipid-reducing agents].
    Sailer D; Kolb S
    Fortschr Med; 1982 Nov; 100(43):2005-10. PubMed ID: 7152437
    [No Abstract]   [Full Text] [Related]  

  • 34. Clofibrate and dalargin increase luminol-dependent chemiluminescence of mouse blood.
    Mushtakova VM; Rogovin VV
    Bull Exp Biol Med; 2007 Sep; 144(3):317-8. PubMed ID: 18457025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
    Haacke H; Kolenda KD
    Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypolipidaemic agents (author's transl)].
    Tillement JP; Albengres E; Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of hyperlipidaemias.
    Lewis B
    Proc R Soc Med; 1971 Sep; 64(9):905-8. PubMed ID: 5114287
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
    Casdorph HR
    Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent progress in atherosclerosis research; experimental and clinical aspects.
    Clopath P; Dicato MA
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):21-33. PubMed ID: 359186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.